Previous 10 | Next 10 |
EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appoin...
EDEN PRAIRIE, Minn., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced it has submitted a pre-IND request to...
Miromatrix Medical Inc. (MIRO) Q3 2022 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group Jeff Ross - CEO Brian Niebur - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Disclaimer*: This transcript is designed to be u...
Miromatrix Medical (NASDAQ:MIRO): Q3 GAAP EPS of -$0.25 misses by $0.12. Revenue of $0.1M (flat Y/Y) Press Release For further details see: Miromatrix Medical EPS misses by $0.12
EDEN PRAIRIE, Minn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported third quarter 2021 financial results. ...
EDEN PRAIRIE, Minn., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financia...
EDEN PRAIRIE, Minn., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced it has successfully completed the fir...
EDEN PRAIRIE, Minn., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will be added to th...
EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the hiring of Dr. John Barry as Vice...
EDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced st...
News, Short Squeeze, Breakout and More Instantly...
Miromatrix Medical Inc. Company Name:
MIRO Stock Symbol:
NASDAQ Market:
Miromatrix Medical Inc. Website:
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. (“ Merger Sub ”), has successfully completed the previously announced tender...
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. (“ Merger Sub ”), a wholly owned subsidiary of United Therapeutics, to acquire all...
NEW YORK, NY / ACCESSWIRE / November 18, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CapStar Financial Holdings, Inc. ...